Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches

Fig. 6

Effect of thymoquinone (TQ), piperine (PIP), and sorafenib (SOR) and their combinations on cell cycle distribution of MDA-MB-231 cells. Cell cycle analysis was performed using flow cytometry. Representative histograms are shown (A), Percentage of cells in each cell cycle phases (B). Data are expressed as the mean ± SEM; n = 3. Means within columns carrying * are significantly different at (p ˂0.05), ** (p ˂ 0.01), *** (p ˂ 0.001) and **** (p ˂ 0.0001)

Back to article page